Hos patienter med påvist knoglemarvs- infiltrerende infektion eller malignitet bør det overvejes at behandle den underliggende tilstand samtidig med at neutropenien behandles med filgrastim.
In patients with known bone marrow-infiltrating infections or malignancy, consider appropriate therapy for treatment of the underlying condition in addition to administration of filgrastim for treatment of neutropenia.